Page 2 - Abbott
Abbott likely to withdraw high-end stents
Any drug brought under price control can be withdrawn after providing 6-month notice to NPPA
 "Abbott likely to withdraw high-end stents")
Abbott: Real-life stories put the spotlight on health
A new 360-degree campaign by drug maker Abbott features television and radio ads urging people to live each day fully
 "Abbott: Real-life stories put the spotlight on health")
Abbott India names Ambati Venu as its MD
Venu will be based out of Mumbai and report to Bhasker Iyer, Vice President, Established Pharmaceuticals Division
 "Abbott India names Ambati Venu as its MD")
Abbott India Q1 net up 10% at Rs 74 crore
Shares of Abbott India on Friday closed at Rs 4,731.45 on BSE, up 0.62 per cent from the previous close
Merger agreement with Abbott on: Alere CEO
The two companies had signed an agreement of merger estimated at $5.8 billion
Medicines had expired by the time we got regulator's alert: Abbott
No analytical testing was possible on the expired batch of the epilepsy drug, Mazetol SR 200, Abbott said
 "Medicines had expired by the time we got regulator's alert: Abbott")
Abbott India says to comply with government order on drugs ban
India banned 344 drug combinations after a govt panel of experts found they had 'no therapeutic justification'
 "Abbott India says to comply with government order on drugs ban")
Abbott India says to comply with government order on drugs ban
India has banned 344 drug combinations after a govt panel of experts found they had no 'therapeutic justification'
